# Biomarkers of Prednisolone Treatment (P05888)

> **NCT00971724** · NA · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 72 (actual)

## Conditions studied

- Insulin Resistance
- Hyperglycemia
- Glucose Intolerance

## Interventions

- **DRUG:** Placebo
- **DRUG:** Prednisolone

## Key facts

- **NCT ID:** NCT00971724
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2006-10
- **Final completion:** 2008-03
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2015-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00971724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00971724, "Biomarkers of Prednisolone Treatment (P05888)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00971724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*